High concordance of BAP1 and PBRM1 expression in patient-matched primary and metastatic ccRCC tumors.

被引：1
|
作者：
Shreders, Amanda
Joseph, Richard Wayne
Serie, Daniel
Kapur, Payal
Ho, Thai Huu
Eckel-Passow, Jeanette
Brugarolas, James
Parker, Alexander S.
机构：
[1] Mayo Clin, Jacksonville, FL USA
[2] Texas So Univ, Med Ctr, Dallas, TX USA
[3] Mayo Clin, Scottsdale, AZ USA
[4] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.507
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
507
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Concordance of BAP1, PBRM1, Ki-67, and TOPOIIa protein expression in primary clear cell renal cell carcinoma tumors and patient-matched metastatic tumors
    Eckel-Passow, Jeanette E.
    Serie, Daniel J.
    Cheville, John C.
    Ho, Thai H.
    Harrington, Sue M.
    Hilton, Tracy
    Lohse, Christine
    Shreders, Amanda
    Kapur, Payal
    Brugarolas, James
    Thompson, R. Houston
    Leibovich, Bradley C.
    Kwon, Eugene D.
    Joseph, Richard W.
    Parker, Alexander S.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22
  • [2] PBRM1 and BAP1 expression in renal cell carcinoma
    Kuthi, L.
    Fallmann, E.
    Jenei, A.
    Posfai, B.
    Maraz, A.
    [J]. VIRCHOWS ARCHIV, 2018, 473 : S44 - S44
  • [3] BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
    Jeanette E. Eckel-Passow
    Daniel J. Serie
    John C. Cheville
    Thai H. Ho
    Payal Kapur
    James Brugarolas
    R. Houston Thompson
    Bradley C. Leibovich
    Eugene D. Kwon
    Richard W. Joseph
    Alexander S. Parker
    [J]. BMC Urology, 17
  • [4] BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
    Eckel-Passow, Jeanette E.
    Serie, Daniel J.
    Cheville, John C.
    Ho, Thai H.
    Kapur, Payal
    Brugarolas, James
    Thompson, R. Houston
    Leibovich, Bradley C.
    Kwon, Eugene D.
    Joseph, Richard W.
    Parker, Alexander S.
    [J]. BMC UROLOGY, 2017, 17 : 1 - 7
  • [5] Prognostic role of BAP1 and PBRM1 expression in intrahepatic cholangiocarcinoma
    Sarcognato, S.
    Gringeri, E.
    Fassan, M.
    Di Giunta, M.
    Guzzardo, V.
    Cillo, U.
    Guido, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 39 - 39
  • [6] Prognostic meaning of BAP1 and PBRM1 expression in intrahepatic cholangiocarcinoma
    Sarcognato, S.
    Gringeri, E.
    Fassan, M.
    Di Giunta, M.
    Guzzardo, V.
    Cillo, U.
    Guido, M.
    [J]. VIRCHOWS ARCHIV, 2017, 471 : S6 - S6
  • [7] Bap1 and Pbrm1 determine tumour grade
    不详
    [J]. NATURE REVIEWS UROLOGY, 2017, 14 (07) : 391 - 391
  • [8] PBRM1 and BAP1 as Novel Targets for Renal Cell Carcinoma
    Brugarolas, James
    [J]. CANCER JOURNAL, 2013, 19 (04): : 324 - 332
  • [9] Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression
    Joseph, Richard W.
    Kapur, Payal
    Serie, Daniel J.
    Parasramka, Mansi
    Ho, Thai H.
    Cheville, John C.
    Frenkel, Eugene
    Parker, Alexander S.
    Brugarolas, James
    [J]. JOURNAL OF UROLOGY, 2016, 195 (01): : 180 - 187
  • [10] Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss
    Misumi, Kento
    Hayashi, Akimasa
    Shibahara, Junji
    Arita, Junichi
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    Fukayama, Masashi
    [J]. HISTOPATHOLOGY, 2017, 70 (05) : 766 - 774
12345